Skip to content
Allegro Ophthalmics - From Theory to Therapy
  • About
    • Company
    • Management
    • Board of Directors
    • Scientific Advisors
  • Science
  • Pipeline
    • Pipeline
    • Risuteganib
    • ALG-1007
    • Clinical Trials
  • Therapeutic Areas
    • Dry AMD
    • Dry Eye Disease
  • News
    • Press Releases
    • Allegro in the News
    • Events

“BLOG: Still Much Progress Ahead in Retina”

Posted on February 14, 2017 | by Allegro Ophthalmics, LLC

John A. Hovanesian, MD, FACS, focuses his blog on new technologies and innovations and how ophthalmic practices can best incorporate them to benefit patients

To read the article, please visit Ocular Surgery News: “BLOG: Still Much Progress Ahead in Retina”

Posted in News Features
Allegro Ophthalmics - From Theory to Therapy

Setting the pace in ocular care
Read More >

Allegro Ophthalmics LLC
31473 Rancho Viejo Road, Suite 204
San Juan Capistrano, CA 92675, USA

Phone: +1 949.940.8130
Email: info@allegroeye.com

RECENT NEWS

Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meeting
April 27, 2022

AffaMed Therapeutics Enters into a Licensing Agreement with Hanmi Pharmaceutical to Develop and Commercialize Risuteganib (Luminate®) as a First-In-Class Treatment for Intermediate Dry AMD Patients in Greater China
January 3, 2022

  • About
  • Science
  • Pipeline
  • Therapeutic Areas
  • News
  • Careers
  • Contact Us
© 2022 Allegro Ophthalmics, LLC. All rights reserved. | Privacy Policy | Terms of Use